Aan een vriend sturen
RSS
google +
Versie om af te drukken

Nieuws (Illegale drugs)

This section on health in the EU has been created as a trustworthy gateway to a wide range of information and data on health-related issues and activities at both European, national and international level. The content is produced by the European Commission, the Member States of the EU and the European Economic Area (EEA), plus EU candidate countries; by international organisations; and by pan-European non-governmental organisations in the area of public health.

Just published: Emergency health consequences of cocaine use in Europe    europa.eu

This study reveals the substantial levels of morbidity related to cocaine use, translated into the large number of cocaine cases seen in various emergency settings in European countries. This health [...]

Just published: Literature review on levels of harm    europa.eu

This report presents the findings of a literature review to identify the most frequently occurring patterns of use and their relation to harm in users of opioids, powder and crack cocaine, and meth/a[...]

Just published: Literature review on levels of harm    europa.eu

This report presents the findings of a literature review to identify the most frequently occurring patterns of use and their relation to harm in users of opioids, powder and crack cocaine, and meth/a[...]

Periodic Report Summary - DOPAMINE NEURON CODE (Developmental Transcription Factors in Dopamine Neuron Maintenance)    europa.eumsw8

KAROLINSKA INSTITUTET Summary description of the project objectives This project aimed at characterising the function of transcription factors expressed in late maturation and adult midbrain dopamine[...]

Final Report Summary - DOPAMINE NEURON CODE (Developmental Transcription Factors in Dopamine Neuron Maintenance)    europa.eumsw8

KAROLINSKA INSTITUTET A fundamental problem in biology has been to understand how the tremendous cellular diversity within the central nervous system is generated during embryonic development. One ce[...]

Scientific guideline: Concept paper on review and update of European Medicines Agency guidelines to implement best practice with regard to 3Rs (replacement, reduction and refinement) in regulatory testing of medicinal products, draft: consultation open    europa.eu

The Joint CHMP/CVMP ad-hoc expert group on the application of the 3Rs in the regulatory testing of medicinal products (JEG 3Rs), in coordination with relevant CHMP and CVMP working parties, has been [...]

Just published: Risk assessment of 4-MA    europa.eu

This report presents the data and findings of the risk assessment on the new psychoactive substance, 4-methylamphetamine, that was conducted by the Scientific Committee of the EMCDDA. Concerns over t[...]

Just published: 5-IT risk assessment    europa.eu

This report presents the data and findings of the risk assessment on the new psychoactive substance, 5-(2-aminopropyl)indole, that was conducted by the Scientific Committee of the EMCDDA. Concerns ov[...]

Just published: Risk assessment of 4-MA    europa.eu

This report presents the data and findings of the risk assessment on the new psychoactive substance, 4-methylamphetamine, that was conducted by the Scientific Committee of the EMCDDA. Concerns over t[...]

Just published: Joint report on AH-7921    europa.eu

The EMCDDA-Europol Joint Report on new psychoactive substance AH-7921 (3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide), submitted in December 2013 to the Council of the EU, the Europea[...]

Just published: Joint Report on MDPV    europa.eu

The EMCDDA-Europol Joint Report on new psychoactive substance MDPV (3,4-methylenedioxypyrovalerone), submitted in December 2013 to the Council of the EU, the European Commission and the EMA. After as[...]

Just published: Joint Report on methoxetamine    europa.eu

The EMCDDA-Europol joint report on new psychoactive substance methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone), submitted in December 2013 to the Council of the EU, the European Commis[...]

EU drugs agency announces new Scientific Committee line-up    europa.eu

The new EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) Scientific Committee starts a fresh mandate this month, with 15 high-level scientists appointed to serve for the period 2014–1[...]

Just published: Drug supply reduction and internal security policies in the EU    europa.eu

Drug supply reduction and internal security policies in the EU Drug supply reduction and internal security policies in the European Union: an overview The production and trafficking of illicit drugs[...]

Just published: Drug supply reduction and internal security policies in the EU    europa.eu

The production and trafficking of illicit drugs poses complex and interlinked problems, which have a negative impact on public health and the security and stability of society. Focusing on actions di[...]

Improving noise reduction    europa.eu

The SILENTWOOD project has developed sophisticated noise-reducing wall panels and doors. These multilayered wood-based panels with enhanced acoustic insulating properties for applications on doors an[...]

Eurocare presents at the 'Sharing evidence to improve addiction prevention and harm reduction' event    eurocare.org

This week Eurocare has presented at a workshop organised by the Executive Agency for Health and Consumers (EAHC) and hosted by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), in[...]

ESMO-led collaborative opioid survey published today    uicc.org

Untreated cancer pain shown as a `scandal of global proportions' Thursday, 28 November - R esults from the Global Opioid Policy Initiative (GOPI) project have just been published in Annals of Oncolog[...]

Disclaimer

The European Commission is solely responsible for information present on EU-level websites, information present in the Portal originated by the Commission. National-level information is provided by the Member States concerned and Member States are solely responsible for the accuracy of the information. Likewise, the European Commission is not responsible for information on non-governmental organisations and international organisations websites. The European Union is committed to user privacy. Read more concerning the Legal Notice.
Further questions can be answered through the Contact page. The Health-EU portal supports principles and measures to increase the credibility of information on the net. It complies with the HONcode standard for trustworthy health information: verify here.